CLIENT IMPACT
Chief Executive Officer & President
TCR² Therapeutics
GARRY MENZEL
LEAD's placement of TCR²'s CTO and Chief Business & Strategy Officer had a significant impact. Peter Olagunju swiftly optimized manufacturing and showcased remarkable leadership acumen, demonstrating CEO succession potential. For our board, finding a CBO with prior threshold-level exit experience was paramount, and Rosemary Harrison's partnership and pivotal role in the Adaptimmune merger validated that decision.
Co-founder + Managing Partner
Vensana Capital / Curate Biosciences
JUSTIN KLEIN
We worked with LEAD on four high priority executive remits, including a CEO engagement and two Independent Director additions to our board. Stephanie was strategic, collaborative, helped us define candidate phenotypes, and evaluate talent against our specific needs. LEAD's team imparted a level of value and dedication that set them apart from other retained groups and has accelerated Curate's progress in achieving our mission.
Co-founder, Director and CEO
Emeritus at Iridia
JIM LINTON
Finding a CEO replacement to lead the next critical phases of our approach to storing digital data inside strands of DNA was paramount to a vision of delivering a novel and scalable DNA storage solution. Stephanie was up for the challenge of working with a Board with high expectations. She has a strong grasp of the Molecular Bio landscape and delved into critical technical + leadership aspects to identity a "unicorn" CEO in Murali Prahalad.
Chief Executive Officer
Santa Ana Bio
PETER EMTAGE
I have worked with Stephanie from both a client and candidate perspective. She is the consummate professional with unparalleled contacts across the biotechnology sphere. Stephanie is proactive, deeply knowledgeable about the cell + gene therapy landscape, and an insightful individual who brings a strategic mindset to a search process. She acts with the utmost of integrity, and I highly recommend LEAD for critical executive leadership assignments.
Chief People Officer + Head of Medical Affairs, TCR² Therapeutics
ANGELA JUSTICE
Working with LEAD was a game-changer. Within weeks, we were interviewing top-tier candidates for a Chief Business & Strategy Officer. In just three months, we hired Rosemary Harrison - an invaluable addition to our team who played a pivotal role in our merger. LEAD's expertise, personalized approach, and keen insights were instrumental and transformative in building our high-performing executive team.
Chief Executive Officer + Co-founder
Metagenomi
BRIAN THOMAS
As a small, but fast-growing biotech company, finding the right executives has been crucial for sustaining our momentum. Stephanie is a seasoned expert. She lays out a clear + strategic path and provides thoughtful insight. She has a deep understanding of the cell + gene field and her network has been critical to our efforts. In working with LEAD, we recognized we have a partner committed to our success.
TESTIMONIALS
BUILDING
executive teams and boards ~ 30+ years experience
SERVING
as strategic thought partners ~ 4 placements on average per Co.
PARTNERING
with urgency ~ 3 month placement average
IMPACTING
the progression of novel modalities ~ 5 new modality approvals
EXECUTIVE SEARCH EXPERTS
Board Director
Scientific Advisory Board
Chief Executive Officer
Chief Operating Officer
Chief Financial Officer
Chief Scientific Officer
Chief Technical Officer
Chief Medical Officer
Chief Commercial Officer
Chief Regulatory Officer
REMIT
Small Molecules
Biologics
Cell Therapy
Gene Therapy + Delivery
RNA Therapeutics
MODALITY
Oncology
Immunology
Autoimmune + Inflammation
Cardiovascular + Metabolic
Central Nervous System
Respiratory
Infectious
Gastrointestinal
THERAPEUTIC AREA
From STEALTH
to SERIES FUNDING through IPO
and GROWTH
Co. Stage
WHERE WE FOCUS + OPERATE
Our client and candidate relationships underpin each and every effort to ensure a compelling constellation of talent in the life sciences industry.
Let's grow your team.
WE ARE INVESTED IN THE PATHWAYS YOU LEAD
